Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this trial is to investigate the coping strategies/physiological flexibility construct in patients hospitalized for ischemic cardiovascular disease and the possible association with recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up, the patient's decision to participate to clinical trials approved in the center and the adherence to cardiovascular medications.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| coping strategies and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death during the follow up period (2 years±14 days from index hospitalization) | coping strategies (evaluated using Brief COPE test) and the recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up period (2 years±14 days from index hospitalization) | 2 years (±14 days) from index hospitalization |
| psychological flexibility and the recurrence any hospitalization and type thereof, myocardial infarction, stroke and death during the follow up period (2 years±14 days from index hospitalization) | psychological flexibility construct (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up period (2 years±14 days from index hospitalization) | 2 years (±14 days) from index hospitalization |
| coping strategies and the patient's decision to participate to the clinical trials approved in the centres | coping strategies (evaluated using Brief COPE test) and the patient's decision to participate to the clinical trials approved in the centres | at discharge of index hospitalization (up to 4 weeks) |
| psychological flexibility and the patient's decision to participate to the clinical trials approved in the centres | psychological flexibility construct (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the patient's decision to participate to the clinical trials approved in the centres | at discharge of index hospitalization (up to 4 weeks) |
| coping strategies and the adherence to cardiovascular medications |
| Measure | Description | Time Frame |
|---|---|---|
| each coping strategy and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death | each coping strategy (evaluated using Brief COPE test) and the recurrence of clinical events type (any hospitalization and type thereof, myocardial infarction, stroke and death) | 2 years (±14 days) from index hospitalization |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients with age ≥ 18 years old and admission to the hospital for ischemic cardiovascular disease.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marco Valgimigli, M.D., Ph.D | Contact | +410918115111 | marco.valgimigli@eoc.ch | |
| enrico frigoli, M.D. | Contact | enricofrigoli@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Marco Valgimigli, M.D., Ph.D | Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Enrico Frigoli | Recruiting | Lugano | 6900 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D013315 | Stress, Psychological |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
coping strategies (evaluated using Brief COPE test) and the adherence to cardiovascular medications |
| 2 years (±14 days) from index hospitalization |
| psychological flexibility and the adherence to cardiovascular medications | psychological flexibility construct (evaluated using MPFI test and - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the adherence to cardiovascular medications | 2 years (±14 days) from index hospitalization |
| each component of psychological flexibility model and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death | each component of psychological flexibility model (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the recurrence of clinical events type (any hospitalization and type thereof, myocardial infarction, stroke and death) | 2 years (±14 days) from index hospitalization |
| each coping strategy (evaluated using Brief COPE test) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial | each coping strategy (evaluated using Brief COPE test) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial, since it requires copying with the patient decision to self-administer treatment unlike other studies in which treatment is physician-directed | at discharge of index hospitalization (up to 4 weeks) |
| each component of psychological flexibility and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial | each component of psychological flexibility construct (evaluated using MPFI test and - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial, since it requires copying with the patient decision to self-administer treatment unlike other studies in which treatment is physician-directed | at discharge of index hospitalization (up to 4 weeks) |
| cognitive fusion and recurrence of cardiovascular events | cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and recurrence of cardiovascular events | at 2 years (±14 days) from index hospitalization |
| cognitive fusion and participation to the trials | cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and participation to the trials | at discharge of index hospitalization (up to 4 weeks) |
| cognitive fusion and adherence to cardiovascular medications | cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and adherence to cardiovascular medications | at 2 years (±14 days) from index hospitalization |
| psychological flexibility evaluated with CVD-AAQ test and cardiovascular events | psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and cardiovascular events | at 2 years (±14 days) from index hospitalization |
| psychological flexibility evaluated with CVD-AAQ test and participation to the trials | psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and participation to the trials | at discharge of index hospitalization (up to 4 weeks) |
| psychological flexibility evaluated with CVD-AAQ test and adherence to cardiovascular medications | psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and adherence to cardiovascular medications | at 2 years (±14 days) from index hospitalization |